SuperSonic Imagine to Present Newly Upgraded Aixplorer(R) Ultrasound Platform at RSNA 2016 - Seite 2

SuperSonic Imagine will demonstrate to RSNA attendees its Fusion, Navigation & Needle Guidance technology. Aixplorer's new fusion and navigation features enable users to fuse real-time ultrasound images with magnetic resonance imaging, computed tomography, positron emission tomography and 3D ultrasound, as well as with other exclusive Aixplorer modes such as SWE, Angio PL.U.S. or TriVu. This combined visualization is designed to leverage the simultaneous real-time benefits of multiple modalities for exams in complex cases, as well as for interventional imaging such as biopsy guidance or therapy such as RF ablation.

For the first time at RSNA, SuperSonic Imagine will perform live demonstrations with models at the booth.

* Drs. Xi Lin, Anhua Li and Cai Chang will present the results of the breast study entitled, "Assessment of Shear Wave Elastography in the Ultrasonic Diagnosis of Breast Cancer in Chinese Patients: The BE3 Multicenter Study of 2,262 Masses."

About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. In addition to providing exceptional image quality, this unique technology is the foundation of several innovations which have changed the paradigm of ultrasound imaging: ShearWave™ Elastography (SWE™), UltraFast™ Doppler, Angio PL.U.S - Planewave UltraSensitive™ Imaging and more recently TriVu.

ShearWave Elastography allows physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This criteria has become an important parameter in diagnosing potentially malignant tissue or other diseased tissue. As of today, over 300 peer-reviewed publications have demonstrated the value of SWE for the clinical management of patients with a wide range of diseases. UltraFast Doppler combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam, providing physicians with exam results simultaneously and helping to increase patient throughput. The latest innovation, Angio PL.U.S, provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging.

SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in key global markets. SuperSonic Imagine is a listed company since April 2014 on the Euronext, symbol SSI.

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

Contact information:
SuperSonic Imagine
Bernard Doorenbos
CEO
Email Contact
[phone]

SuperSonic Imagine
Marketing & Communication
Emmanuelle Vella
Email Contact
[phone]

NewCap
Investor Relations - EU
Pierre Laurent / Florent Alba
Email Contact
[phone]

Pascale Communication
Media Relations - US
Amy Phillips
Email Contact
[phone]